| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 130,405 | 4,650 | 4,510 | 636 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 130,405 | 4,650 | 4,510 | 636 | | | Operating Expenses | | Research Development | 9,085 | 10,097 | 22,639 | 23,031 | | Selling General and Administrative | 3,148 | 3,006 | 4,070 | 3,470 | | Non Recurring |
-
|
-
| 1,236 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 118,172 | (8,453) | (23,435) | (25,865) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (142) | 43 | 36 | 401 | | Earnings Before Interest And Taxes | 118,030 | (8,410) | (23,399) | (25,464) | | Interest Expense | 70 | 85 | 100 | 489 | | Income Before Tax | 117,960 | (8,495) | (23,499) | (25,953) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 117,960 | (8,495) | (23,499) | (25,953) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 118,119 | (8,495) | (23,499) | (25,953) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $118,119 | ($8,495) | ($23,499) | ($25,953) |
|
0.29% Nasdaq 
Income Statement
